News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Blum Michael Lee
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/27/2023 |
4
| Blum Michael Lee (Chief Commercial Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 104,000 options to buy
@ $1.6, valued at
$166.4k
Granted 17,000 restricted stock units
@ $0 |
|
| 01/20/2023 |
3/A
| Blum Michael Lee (Chief Commercial Officer) has filed a Form 3/A on Homology Medicines, Inc. |
| 01/20/2023 |
4/A
| Blum Michael Lee (Chief Commercial Officer) has filed a Form 4 on Homology Medicines, Inc. |
| 01/11/2023 |
4
| Blum Michael Lee (Chief Commercial Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Sold 2,454 shares
@ $1.3904, valued at
$3.4k
|
|
| 01/04/2023 |
4
| Blum Michael Lee (Chief Commercial Officer) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Exercised 2,640 restricted stock units
@ $0
Exercised 4,950 restricted stock units
@ $0 |
|
| 03/11/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|